Skip to content

Adding details on ExpansionRx-OpenADMET blind challenge. #31

New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Merged
mallory-tollefson merged 2 commits into from
Oct 27, 2025
Merged

Adding details on ExpansionRx-OpenADMET blind challenge. #31

Changes from all commits
Commits
Show all changes
2 commits
Select commit Hold shift + click to select a range
d09768d
Adding details on ExpansionRx-OpenADMET blind challenge.
mallory-tollefson Oct 27, 2025
b8c9e2f
Adding dates.
mallory-tollefson Oct 27, 2025
File filter

Filter by extension

Filter by extension
Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
10 changes: 10 additions & 0 deletions content/community/events/blind-challenges.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -9,6 +9,16 @@ part: 20

![Events](/images/event.svg)

### ExpansionRx × OpenADMET Blind Challenge

Blind challenges are a cornerstone for benchmarking and improving predictive modeling in molecular sciences. Following in the tradition of community efforts like CASP and other open benchmarking initiatives, this challenge invites researchers to test and refine AI-driven ADMET modeling approaches on a high-quality experimental dataset.

OpenADMET, in collaboration with Expansion Therapeutics and Collaborative Drug Discovery (CDD Vault), is launching the ExpansionRx–OpenADMET Blind Challenge on October 27th, 2025, focused on predicting key ADMET properties for small molecules using both traditional and machine learning approaches. Participants will gain access to carefully curated data through CDD Vault Public and Hugging Face, enabling transparent, reproducible evaluation of predictive performance. Submissions close on January 19th, 2026.

This challenge exemplifies the OpenADMET mission: accelerating open, community-driven progress in the modeling of the “avoidome” — the molecular features that drive toxicity, metabolic instability, and off-target effects. We welcome participants from academia, biotech, pharma, and beyond to join this collaborative experiment in open science.

If you missed our live announcement webinar or want to hear more from the organizers, you can visit our [blog](https://openadmet.ghost.io/openadmet-expansionrx-blind-challenge/) and [YouTube](https://www.youtube.com/watch?v=pJlcAlokk3c) for updates.


### ASAP x Polaris x OpenADMET Blind Challenge

Expand Down